Hims & Hers Health (NYSE:HIMS – Get Free Report) and Wellgistics Health (NASDAQ:MEDS – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.
Institutional and Insider Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 27.0% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Volatility and Risk
Hims & Hers Health has a beta of 2.44, meaning that its stock price is 144% more volatile than the S&P 500. Comparatively, Wellgistics Health has a beta of -3.51, meaning that its stock price is 451% less volatile than the S&P 500.
Profitability
This table compares Hims & Hers Health and Wellgistics Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | -5.51% | -6.51% | -1.20% |
| Wellgistics Health | -1,100.16% | N/A | -171.81% |
Valuation & Earnings
This table compares Hims & Hers Health and Wellgistics Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $2.35 billion | 2.90 | $128.37 million | ($0.63) | -46.27 |
| Wellgistics Health | $23.34 million | 0.38 | -$101.28 million | ($46.13) | -0.06 |
Hims & Hers Health has higher revenue and earnings than Wellgistics Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations for Hims & Hers Health and Wellgistics Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 1 | 11 | 3 | 0 | 2.13 |
| Wellgistics Health | 1 | 0 | 0 | 0 | 1.00 |
Hims & Hers Health currently has a consensus target price of $32.43, suggesting a potential upside of 11.25%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, equities analysts plainly believe Hims & Hers Health is more favorable than Wellgistics Health.
Summary
Hims & Hers Health beats Wellgistics Health on 11 of the 13 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Wellgistics Health
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
